Mohamed Hassan Sayegh

Mohamed Hassan Sayegh's AcademicInfluence.com Rankings

Medical

#1533

World Rank

#1883

Historical Rank

Cardiology

#122

World Rank

#125

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Mohamed Hassan Sayegh Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mohamed Hassan Sayegh's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis (2007) (1923)
Identification of cells initiating human melanomas (2008) (1171)
Tissue expression of PD-L1 mediates peripheral T cell tolerance (2006) (1123)
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. (1994) (937)
Delayed graft function in kidney transplantation (2004) (929)
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice (2003) (754)
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance (1999) (658)
The role of T-cell costimulatory activation pathways in transplant rejection. (1998) (605)
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. (2005) (566)
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2 (1995) (564)
Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1 (2001) (539)
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment (2000) (526)
Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes (1998) (513)
Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis (2003) (509)
Immunosuppressive strategies in transplantation (1999) (452)
Homeostatic proliferation is a barrier to transplantation tolerance (2004) (444)
Effects of explosive brain death on cytokine activation of peripheral organs in the rat. (1998) (433)
Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. (2011) (426)
Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. (1996) (421)
Anaritide in Acute Tubular Necrosis (1997) (408)
Transplantation 50 years later--progress, challenges, and promises. (2004) (408)
A critical role for the programmed death ligand 1 in fetomaternal tolerance (2005) (395)
Extrathymic T Cell Deletion and Allogeneic Stem Cell Engraftment Induced with Costimulatory Blockade Is Followed by Central T Cell Tolerance (1998) (375)
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells (2008) (374)
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes1 (2009) (373)
A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. (2006) (368)
Immunomodulation by Mesenchymal Stem Cells A Potential Therapeutic Strategy for Type 1 Diabetes (2008) (331)
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1–PD-L1 pathway (2006) (313)
Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. (1997) (307)
A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy (2008) (305)
T‐cell costimulatory pathways in allograft rejection and tolerance (2003) (297)
Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. (2003) (294)
Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. (1991) (275)
Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. (2003) (271)
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. (2001) (245)
Regulation of Progenitor Cell Fusion by ABCB5 P-glycoprotein, a Novel Human ATP-binding Cassette Transporter* (2003) (243)
The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. (1999) (242)
Immunomodulation by Mesenchymal Stem Cells (2008) (241)
Regulatory CD25+ T cells in human kidney transplant recipients. (2003) (236)
Calcineurin Inhibitors: 40 Years Later, Can’t Live Without … (2013) (235)
The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. (1997) (233)
Maternal Acceptance of the Fetus: True Human Tolerance (2007) (232)
CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. (1995) (228)
The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. (2004) (226)
Proinflammatory functions of vascular endothelial growth factor in alloimmunity. (2003) (225)
Allograft rejection mediated by memory T cells is resistant to regulation (2007) (205)
Mechanisms of T cell recognition of alloantigen. The role of peptides. (1994) (205)
Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. (1998) (202)
CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism 1 (2003) (199)
Costimulatory pathways in transplantation: challenges and new developments (2009) (194)
Role of the Programmed Death-1 Pathway in Regulation of Alloimmune Responses In Vivo1 (2005) (193)
Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. (1996) (183)
CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. (2000) (182)
Memory T cells: a hurdle to immunologic tolerance. (2003) (177)
The role of novel T cell costimulatory pathways in autoimmunity and transplantation. (2002) (176)
CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. (1999) (174)
Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. (1998) (172)
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. (1996) (172)
Organ trafficking and transplant tourism and commercialism : the declaration of Istanbul (2008) (170)
Analysis of the Role of Negative T Cell Costimulatory Pathways in CD4 and CD8 T Cell-Mediated Alloimmune Responses In Vivo1 (2005) (165)
Accelerated Memory Cell Homeostasis during T Cell Depletion and Approaches to Overcome It (2006) (160)
The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo (2011) (159)
The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. (2003) (157)
Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat. (1992) (156)
Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. (1996) (152)
The Link between the PDL1 Costimulatory Pathway and Th17 in Fetomaternal Tolerance (2011) (150)
Role of indirect allorecognition in allograft rejection. (1996) (148)
Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. (1995) (147)
The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. (2000) (146)
A Link between PDL1 and T Regulatory Cells in Fetomaternal Tolerance1 (2007) (143)
Thymic recognition of class II major histocompatibility complex allopeptides induces donor-specific unresponsiveness to renal allografts. (1993) (141)
Chronic allograft dysfunction: mechanisms and new approaches to therapy. (2000) (140)
Targeting CD22 Reprograms B-Cells and Reverses Autoimmune Diabetes (2008) (138)
Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function (2007) (138)
Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy. (1994) (137)
Endothelial Cells Modify the Costimulatory Capacity of Transmigrating Leukocytes and Promote Cd28-Mediated Cd4+ T Cell Alloactivation (1999) (136)
Induction of "infectious" tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. (1996) (134)
Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. (2002) (134)
Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. (1997) (131)
CD28-independent Costimulation of T Cells in Alloimmune Responses1 (2001) (131)
Cutting Edge: Recipient MHC Class II Expression Is Required to Achieve Long-Term Survival of Murine Cardiac Allografts After Costimulatory Blockade1 (2001) (131)
Critical, but Conditional, Role of OX40 in Memory T Cell-Mediated Rejection1 (2006) (130)
Specificity of CD4+CD25+ Regulatory T Cell Function in Alloimmunity1 (2006) (129)
Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. (1998) (129)
Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. (1999) (129)
Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. (1993) (128)
Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes (2010) (128)
Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy (2001) (128)
Transplant nephrectomy improves survival following a failed renal allograft. (2010) (126)
Peripheral Deletion After Bone Marrow Transplantation with Costimulatory Blockade Has Features of Both Activation-Induced Cell Death and Passive Cell Death1 (2001) (125)
Challenges to achieving clinical transplantation tolerance. (2001) (125)
Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. (1995) (124)
Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. (1997) (124)
Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo (1995) (123)
Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. (1997) (121)
The Novel Costimulatory Programmed Death Ligand 1/B7.1 Pathway Is Functional in Inhibiting Alloimmune Responses In Vivo (2011) (120)
Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. (1997) (118)
Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. (2003) (118)
Zeisberg, E.M. et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13, 952-961 (2007) (117)
Critical Role of OX40 in CD28 and CD154-Independent Rejection1 (2004) (114)
The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. (2008) (112)
CD70 Signaling Is Critical for CD28-Independent CD8+ T Cell-Mediated Alloimmune Responses In Vivo1 (2005) (111)
Role of podocyte B7-1 in diabetic nephropathy. (2014) (110)
Why do we reject a graft? Role of indirect allorecognition in graft rejection. (1999) (109)
The in vivo mechanism of action of CTLA4Ig. (1996) (108)
Mechanisms of PDL1-mediated regulation of autoimmune diabetes. (2007) (108)
Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. (1994) (108)
Differential Role of Programmed Death-Ligand 1 and Programmed Death-Ligand 2 in Regulating the Susceptibility and Chronic Progression of Experimental Autoimmune Encephalomyelitis1 (2006) (106)
CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. (1997) (105)
PDL1 Is Required for Peripheral Transplantation Tolerance and Protection from Chronic Allograft Rejection1 (2007) (105)
New Insights Into the Interactions Between T-Cell Costimulatory Blockade and Conventional Immunosuppressive Drugs (2002) (103)
Targeting Signal 1 Through CD45RB Synergizes with CD40 Ligand Blockade and Promotes Long Term Engraftment and Tolerance in Stringent Transplant Models1 (2001) (102)
CTLA4-Ig: a novel immunosuppressive agent (2000) (100)
CD4+ mononuclear cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. (1994) (100)
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. (1997) (100)
THE CD154-CD40 COSTIMULATORY PATHWAY IN TRANSPLANTATION (2002) (99)
Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. (2001) (97)
The Role of the CD134-CD134 Ligand Costimulatory Pathway in Alloimmune Responses In Vivo 1 (2003) (97)
The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. (2002) (97)
Mechanisms Underlying Blockade of Allograft Acceptance by TLR Ligands1 (2008) (96)
Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy. (2004) (94)
Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7 (2013) (94)
Chronic Rejection in Experimental Cardiac Transplantation: Studies in the Lewis‐F344 Model (1993) (93)
Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli. (2004) (93)
CD4+ T Cells Regulate Surgical and Postinfectious Adhesion Formation (2002) (93)
DOWN‐REGULATION OF THE IMMUNE RESPONSE TO HISTOCOMPATIBILITY ANTIGENS AND PREVENTION OF SENSITIZATION BY SKIN ALLOGRAFTS BY ORALLY ADMINISTERED ALLOANTIGEN1 (1992) (93)
CD28-independent induction of experimental autoimmune encephalomyelitis. (2001) (90)
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance. (2002) (89)
Role of CXC chemokine receptor 3 pathway in renal ischemic injury. (2006) (89)
Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. (2006) (89)
Critical Role of Donor Tissue Expression of Programmed Death Ligand-1 in Regulating Cardiac Allograft Rejection and Vasculopathy (2008) (88)
Indirect Allorecognition of Mismatched Donor HLA Class II Peptides in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome (2001) (87)
Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size1 (2002) (85)
Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. (2001) (85)
Alloreactive T Cell Responses and Acute Rejection of Single Class II MHC-Disparate Heart Allografts Are under Strict Regulation by CD4+CD25+ T Cells1 (2005) (84)
A rendezvous before rejection: Where do T cells meet transplant antigens? (2002) (84)
Immunomodulatory functions of mesenchymal stem cells (2004) (83)
Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. (1996) (82)
Costimulatory pathways in transplantation (2011) (81)
Differential Role of CCR2 in Islet and Heart Allograft Rejection: Tissue Specificity of Chemokine/Chemokine Receptor Function In Vivo1 (2004) (81)
Cutting Edge: Transplantation Tolerance through Enhanced CTLA-4 Expression 1 (2003) (78)
CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo. (1996) (77)
Thymic Dendritic Cells Express Inducible Nitric Oxide Synthase and Generate Nitric Oxide in Response to Self- and Alloantigens1 (2000) (77)
Interleukin-10+ Regulatory B Cells Arise Within Antigen-Experienced CD40+ B Cells to Maintain Tolerance to Islet Autoantigens (2014) (77)
Kaposi's sarcoma after renal transplantation. (1997) (76)
The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. (2002) (75)
CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. (1993) (75)
Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection (2013) (75)
Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides. (1999) (75)
The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. (1995) (74)
Targeting Tim-1 to overcome resistance to transplantation tolerance mediated by CD8 T17 cells (2009) (74)
Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide (1993) (73)
Modulation of Tissue-Specific Immune Response to Cardiac Myosin Can Prolong Survival of Allogeneic Heart Transplants1 (2002) (73)
T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance induction. (1995) (71)
Targeting the CXCR4–CXCL12 Axis Mobilizes Autologous Hematopoietic Stem Cells and Prolongs Islet Allograft Survival via Programmed Death Ligand 1 (2011) (70)
DEPLETING ANTI-CD4 MONOCLONAL ANTIBODY CURES NEW-ONSET DIABETES, PREVENTS RECURRENT AUTOIMMUNE DIABETES, AND DELAYS ALLOGRAFT REJECTION IN NONOBESE DIABETIC MICE1 (2004) (69)
CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis. (2001) (69)
Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. (2000) (69)
In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity (2012) (68)
The role of donor and recipient B7-1 (CD80) in allograft rejection. (1997) (68)
Immunosuppressive drugs and Tregs: a critical evaluation! (2009) (68)
Human HTm4 is a hematopoietic cell cycle regulator. (2002) (68)
Clinical Transplantation Tolerance: Many Rivers to Cross (2007) (67)
Specific MDR1 P-Glycoprotein Blockade Inhibits Human Alloimmune T Cell Activation In Vitro1 (2001) (66)
The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant. (2002) (65)
Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy. (1998) (65)
Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. (1995) (65)
Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. (2006) (64)
Finally, CTLA4Ig graduates to the clinic. (1999) (63)
Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation. (1996) (62)
Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts. (1997) (62)
A Novel Clinically Relevant Strategy to Abrogate Autoimmunity and Regulate Alloimmunity in NOD Mice (2010) (62)
Role of indirect allorecognition in experimental late acute rejection. (1997) (62)
The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. (1996) (61)
Distinct functions of autoreactive memory and effector CD4+ T cells in experimental autoimmune encephalomyelitis. (2008) (61)
Endothelin in organ transplantation. (1996) (61)
T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen. (1997) (59)
New reagents on the horizon for immune tolerance. (2007) (59)
Allograft Rejection in a New Allospecific CD4+ TCR Transgenic Mouse (2003) (59)
Essential Role of PDL1 Expression on Nonhematopoietic Donor Cells in Acquired Tolerance to Vascularized Cardiac Allografts (2011) (58)
Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice. (2008) (58)
CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. (1997) (57)
Bacterial Pathogens Induce Abscess Formation by CD4+ T-Cell Activation via the CD28–B7-2 Costimulatory Pathway (2000) (56)
Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo. (1996) (56)
Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation. (1998) (56)
Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. (2006) (56)
Different Costimulatory and Growth Factor Requirements for CD4+ and CD8+ T Cell-Mediated Rejection 1 (2004) (56)
Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation‐05 Study (2016) (55)
CTLA-4 up-regulation plays a role in tolerance mediated by CD45 (2001) (54)
T-Cell Costimulatory Pathways in Allograft Rejection and Tolerance (2005) (54)
Anti-CD28 monoclonal antibody therapy prevents chronic rejection of renal allografts in rats. (2002) (53)
The CD154-CD40 T Cell Costimulation Pathway Is Required for Host Sensitization of CD8+ T Cells by Skin Grafts Via Direct Antigen Presentation1 (2002) (52)
Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. (1996) (51)
The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin. (1999) (50)
Peptide-mediated immunosuppression. (1997) (50)
Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes (2014) (50)
Interactions between cyclosporine and newer antidepressant medications. (1998) (49)
Acquired thymic tolerance: role of CTLA4 in the initiation and maintenance of tolerance in a clinically relevant autoimmune disease model. (1999) (49)
ABCB5 Identifies Immunoregulatory Dermal Cells. (2015) (49)
A Novel Clinically Relevant Approach to Tip the Balance Toward Regulation in Stringent Transplant Model (2010) (48)
Indirect allorecognition of donor class I and II major histocompatibility complex peptides promotes the development of transplant vasculopathy. (2001) (47)
Blockade of CD28-B7, But Not CD40-CD154, Prevents Costimulation of Allogeneic Porcine and Xenogeneic Human Anti-Porcine T Cell Responses1 (2000) (47)
Rejection of Mouse Cardiac Allografts by Costimulation in trans1 (2001) (47)
Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. (2000) (47)
A Novel Alloantigen-Specific CD8+PD1+ Regulatory T Cell Induced by ICOS-B7h Blockade In Vivo1 (2007) (47)
Alloreactive T Cell Responses and Acute Rejection of Single Class II MHC-Disparate Heart Allografts Are under Strict Regulation by CD4+CD25+ T Cells. (2005) (47)
Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation. (2004) (46)
Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection. (1998) (46)
Tolerance and chronic rejection. (1997) (46)
Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice. (2003) (45)
Transplantation tolerance: The concept and its applicability (1999) (45)
Further Analysis of the T‐Cell Subsets and Pathways of Murine Cardiac Allograft Rejection (2003) (45)
Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis (1999) (45)
Mesenchymal stem cells express serine protease inhibitor to evade the host immune response. (2011) (45)
Cytokine analysis of human renal allograft aspiration biopsy cultures supernatants predicts acute rejection. (1998) (44)
Characterization of Donor Dendritic Cells and Enhancement of Dendritic Cell Efflux With cc-Chemokine Ligand 21 (2007) (42)
New TCR Transgenic Model for Tracking Allospecific CD4 T‐Cell Activation and Tolerance in Vivo (2003) (42)
Importance of hyperglycemia on the primary function of allogeneic islet transplants1 (2003) (41)
Dual effects of the alloresponse by Th1 and Th2 cells on acute and chronic rejection of allotransplants (2009) (41)
T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection. (2002) (41)
Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. (1998) (40)
Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis. (1999) (40)
T cell recognition of xeno-MHC peptides during concordant xenograft rejection. (1996) (40)
Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin. (1997) (40)
Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. (2005) (39)
Differential effects of oral versus intrathymic administration of polymorphic major histocompatibility complex class II peptides on mononuclear and endothelial cell activation and cytokine expression during a delayed-type hypersensitivity response. (1994) (39)
Requirements for induction and maintenance of peripheral tolerance in stringent allograft models. (2005) (39)
Mechanisms of targeting cd28 by a signaling monoclonal antibody in acute and chronic allograft rejection1 (2002) (39)
Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides (1994) (39)
Rat intestinal epithelial cells present major histocompatibility complex allopeptides to primed T cells. (1994) (38)
Downregulation of intragraft IFN-gamma expression correlates with increased IgG1 alloantibody response following intrathymic immunomodulation of sensitized rat recipients. (1995) (38)
Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy. (1992) (37)
Matrix Embedding Alters the Immune Response Against Endothelial Cells In Vitro and In Vivo (2005) (36)
In vivo mechanisms of acquired thymic tolerance. (1997) (36)
Activation of Alloreactive CD8+ T Cells Operates Via CD4-Dependent and CD4-Independent Mechanisms and Is CD154 Blockade Sensitive 1 (2003) (35)
The thymic way to transplantation tolerance. (1995) (35)
Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. (2002) (35)
Involvement of the direct and indirect pathways of allorecognition in tolerance induction. (2001) (34)
Mechanisms of Tolerance Induced by Donor‐Specific Transfusion and ICOS‐B7h Blockade in a Model of CD4+ T‐Cell‐Mediated Allograft Rejection (2005) (34)
Interaction Between ICOS‐B7RP1 and B7‐CD28 Costimulatory Pathways in Alloimmune Responses In Vivo (2003) (33)
Chronic Kidney Disease, Dialysis, and Transplantation (2010) (32)
Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen. (1998) (32)
Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade. (1999) (32)
The allocation of cadaver kidneys for transplantation in the United States: consensus and controversy. ASN Transplant Advisory Group. American Society of Nephrology. (1999) (32)
The Novel Role of SERPINB9 in Cytotoxic Protection of Human Mesenchymal Stem Cells (2011) (31)
Intact B7‐H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses (2012) (31)
Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection. (1997) (31)
Blocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease. (1999) (30)
The role of costimulatory molecules as targets for new immunosuppressives in transplantation. (2000) (30)
Mechanisms of Oral Tolerance by MHC Peptides (1996) (30)
Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. (1999) (30)
Immune parameters affecting adenoviral vector gene therapy in the brain. (1998) (30)
Role of the ICOS-B7h Costimulatory Pathway in the Pathophysiology of Chronic Allograft Rejection (2005) (29)
Paradoxical Functions of B7: CD28 Costimulation in a MHC Class II‐Mismatched Cardiac Transplant Model (2009) (29)
Immune profile of pediatric renal transplant recipients following alemtuzumab induction. (2012) (29)
Clinical update: immunosuppression minimisation (2007) (29)
Differential effects of B7-1 blockade in the rat experimental autoimmune encephalomyelitis model. (1997) (29)
Novel Insights into the Mechanism of Action of FTY720 in a Transgenic Model of Allograft Rejection: Implications for Therapy of Chronic Rejection1 (2006) (29)
Novel immunotherapeutic strategies using MHC derived peptides. (1996) (28)
A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection1 (2002) (28)
IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response (2011) (28)
CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathy1 (2003) (28)
Matrix adherence of endothelial cells attenuates immune reactivity: induction of hyporesponsiveness in allo‐ and xenogeneic models (2007) (28)
Chronic rejection in experimental cardiac transplantation in a rat model. (1994) (27)
P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes (2018) (27)
Effects of BWH-4 anti-CD4 monoclonal antibody on rat vascularized cardiac allografts before and after engraftment. (1991) (26)
P-glycoprotein--a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity? (2003) (26)
T-cell co-stimulatory blockade in transplantation: two steps forward one step back! (2013) (26)
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon (2021) (25)
Regulation of Postsurgical Fibrosis by the Programmed Death-1 Inhibitory Pathway1 (2004) (25)
Immunomodulatory functions of hyaluronate in the LEW-to-F344 model of chronic cardiac allograft rejection. (1999) (24)
Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts. (1998) (24)
In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide. (1998) (24)
Phenotypic and Functional Differences Between Wild-Type and CCR2−/− Dendritic Cells: Implications for Islet Transplantation (2008) (24)
Defining Th1 and Th2 Immune Responses in a Reciprocal Cytokine Environment In Vivo1 (2004) (24)
Immunomodulatory functions of low-molecular weight hyaluronate in an acute rat renal allograft rejection model. (1999) (23)
Induction of Robust Diabetes Resistance and Prevention of Recurrent Type 1 Diabetes Following Islet Transplantation by Gene Therapy1 (2007) (23)
Membranous Lupus Nephritis in a Renal Allograft: Response to Mycophenolate Mofetil Therapy (2001) (22)
CTLA4Ig-Induced Linked Regulation of Allogeneic T Cell Responses1 (2001) (21)
Clinical transplantation tolerance: the promise and challenges. (2004) (21)
Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. (1995) (21)
Alternative T‐Cell Costimulatory Pathways in Transplant Rejection and Tolerance Induction: Hierarchy or Redundancy? (2003) (20)
Negative T-cell costimulatory pathways: their role in regulating alloimmune responses. (2008) (20)
Indirect Recognition of MHC Class I Allopeptides Accelerates Lung Allograft Rejection in Miniature Swine (2005) (20)
The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction? (2004) (20)
CD160Ig Fusion Protein Targets a Novel Costimulatory Pathway and Prolongs Allograft Survival (2013) (19)
The alloantibody network following intrathymic immunomodulation of sensitized rat recipients of cardiac allografts. (1995) (19)
Core Concepts in the Disorders of Fluid, Electrolytes and Acid-Base Balance (2013) (18)
MECHANISMS OF INDIRECT ALLORECOGNITION (1998) (18)
Differential role of CD4+ cells in the sensitization and effector phases of accelerated graft rejection. (1991) (18)
Maintenance pharmacological immunosuppressive strategies in renal transplantation. (1997) (17)
CD 28B 7 Blockade after Alloantigenic Challenge In Vivo Inhibits Thl Cytokines but Spares Th 2 By (2003) (17)
Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides. (1995) (17)
Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil. (1999) (17)
Blocking cell microtubule assembly inhibits the alloimmune response in vitro and prolongs renal allograft survival by inhibition of Th1 and sparing of Th2 cell function in vivo. (1995) (16)
Indirect allorecognition promotes the development of cardiac allograft vasculopathy. (2001) (16)
Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection. (2001) (16)
Recurrence of glomerulonephritis following renal transplantation (1999) (16)
Chronic Kidney Disease, Dialysis, and Transplantation: A Companion to Brenner and Rector's The Kidney (2019) (16)
Membranous nephropathy in a patient with renal cell carcinoma. (1991) (16)
The importance of targeting the CD4+ T cell subset at the time of antigenic challenge for induction of prolonged vascularized allograft survival. (1992) (15)
TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy. (2004) (15)
Costimulation couture: a designer approach to regulating autoimmunity. (2006) (15)
Faculty Opinions recommendation of Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy. (2008) (15)
Assessment by flow cytometry of intracellular cytokine production in the peripheral blood cells of renal transplant recipients (2004) (15)
Tolerance and chronic rejection. (2001) (14)
Class II MHC allopeptide-specific T-cell clones transfer delayed type hypersensitivity responses in vivo. (1997) (14)
HLA class II-restricted binding of muramyl peptides to B lymphocytes of normal and narcoleptic subjects. (1990) (14)
Anti-CD4 monoclonal antibody effects cellular hyporesponsiveness and prolongs renal allograft survival in the rat. (1989) (14)
Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients. (2016) (14)
Case record of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-2003. A 35-year-old man with early dysfunction of a second renal transplant. (2003) (14)
Inotuzumab Ozogamicin Murine Analog–Mediated B-Cell Depletion Reduces Anti-islet Allo- and Autoimmune Responses (2011) (13)
The cell cycle associated protein, HTm4, is expressed in differentiating cellsof the hematopoietic and central nervous system in mice (2005) (13)
Transplantation tolerance in pediatric recipients: Lessons and challenges (2005) (13)
Late renal allograft failure secondary to thrombotic microangiopathy-human immunodeficiency virus nephropathy. (1994) (13)
Regulatory CD 25 T Cells in Human Kidney Transplant Recipients (2003) (13)
Key role of the alternate complement pathway in hyperacute rejection of rat hearts transplanted into fetal sheep. (1996) (13)
CTLA4Ig-induced linked regulation of allogeneic T cell responses. (2001) (13)
Regulatory T Cells Maintain Peripheral Tolerance to Islet Allografts Induced by Intrathymic Injection of MHC Class I Allopeptides1 (1999) (13)
Induction of immunity and oral tolerance to alloantigen by polymorphic class II major histocompatibility complex allopeptides in the rat. (1993) (12)
Sijilli: a mobile electronic health records system for refugees in low-resource settings. (2019) (12)
Measuring T cell alloreactivity to predict kidney transplant outcomes: are we there yet? (2006) (12)
INTRATHYMIC INJECTION OF DONOR‐SPECIFIC X‐IRRADIATION-SENSITIVE SPLEEN CELLS ABROGATES ACCELERATED REJECTION OF CARDIAC ALLOGRAFTS IN SENSITIZED RATS1 (1994) (12)
Combination Treatment with Donor-Specific Transfusions and Cyclosporine A Induces Long-Term Survival of Cardiac Allografts in Miniature Swine (2005) (12)
Donor-specific transplantation unresponsiveness in sensitized rats following treatment with a nondepleting anti-CD4 MAb is associated with selective intragraft sparing of Th2-like cells. (1995) (12)
Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation. (2019) (11)
A novel mechanism for the immunomodulatory functions of class II MHC-derived peptides. (2003) (11)
T-cell recognition of allograft target antigens (2000) (11)
B cell-targeted therapies in autoimmunity: rationale and progress (2009) (10)
Current and Future Immunosuppressive Therapies Following Transplantation (2001) (10)
Dialysis and Transplantation: A Companion to Brenner & Rector's The Kidney (2000) (10)
Regulatory T cells in transplantation: what we know and what we do not know. (2009) (10)
Why do we reject a graft? Mechanisms of recognition of transplantation antigens (1996) (10)
TIM4 Regulates the Anti-Islet Th2 Alloimmune Response (2015) (10)
Physiologic regulation of alloimmune responses in vivo: the role of CTLA4 and TH1/TH2 cytokines. (2001) (10)
CTLA 4 Ig graduates to the clinic (1999) (9)
Erratum: Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4 +CD25+ T cells (The Journal of Immunology (2005) 174 (3741-3748)) (2005) (9)
The role of indirect recognition of donor MHC class II peptides in cardiac transplantation in miniature swine. (2001) (9)
Effect of hepatocyte growth factor on chronic rejection in rat renal allografts. (1999) (9)
Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen. (2010) (9)
CTLA4Ig: effects on cellular and humoral immunity and macrophage activation. (1997) (9)
The evolution of the immunobiology of co-stimulatory pathways: clinical implications. (2007) (9)
In Memoriam: Charles Bernard Carpenter (2012) (8)
Overcoming cardiac allograft vasculopathy (CAV) by inducing tolerance. (2002) (8)
Role of the CD28:B7 costimulatory interaction in alloimmune responses. (1997) (8)
Donor antigen and transplant tolerance strategies: it takes two to tango! (2004) (8)
Promotion of altruistic donation. (2009) (8)
Clinical transplantation tolerance: a myth no more, but... (2009) (8)
Targeting CD28 to prevent transplant rejection (2014) (8)
Transplantation tolerance. A complex scenario awaiting clinical applicability. (2005) (8)
Use of polyclonal/monoclonal antibody therapies in transplantation (2017) (8)
Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells. (2008) (8)
A novel in vivo regulatory role of P-glycoprotein in alloimmunity. (2010) (8)
Immunomodulatory function of major histocompatibility complex-derived peptides. (1996) (7)
Costimulation Blockade in Transplantation. (2019) (7)
EVIDENCE THAT THERAPEUTIC STRATEGIES TARGETED AT CD4+ CELLS MODULATE ACCELERATED REJECTION OF CARDIAC ALLOGRAFTS IN SENSITIZED RATS BY DIFFERENT MECHANISMS (1992) (7)
Reversing the brain drain: a Lebanese model (2012) (7)
Current and future immunosuppressive therapies: impact on chronic allograft dysfunction. (1997) (7)
A pilot study on the immunological effects of oral administration of donor major histocompatibility complex class II peptides in renal transplant recipients (2008) (7)
Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection. (2011) (6)
Oral immunization with allogeneic splenocytes inhibits development of accelerated but not acute rejection of cardiac grafts: analysis of intragraft effector mechanisms. (1992) (6)
Major histocompatibility complex–derived peptides as novel forms of immunosuppression (1999) (6)
Role of regulatory T cells in the "infectious" tolerance pathway in transplant recipients. (1998) (6)
CD 28-independent Costimulation of T Cells in Alloimmune Responses 1 (2001) (6)
The Limits of Linked Suppression for Regulatory T Cells (2016) (6)
Live Images of Donor Dendritic Cells Trafficking via CX3CR1 Pathway (2016) (6)
Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. (1998) (6)
T cell costimulatory pathways in allograft rejection and tolerance: what's new? (2007) (6)
The role of CD 154-CD 40 versus CD 28B 7 costimulatory pathways in regulating allogeneic Th 1 and Th 2 responses in vivo (2000) (6)
ANALYSIS OF THE ROLE OF NEGATIVE T CELL COSTIMULATORY PATHWAYS IN CD4 AND CD8 MEDIATED ALLOIMMUNE RESPONSES IN VIVO (2004) (6)
Core concepts in renal transplantation (2012) (5)
Effect of gonadectomy on epidermal growth factor values in the gastrointestinal tract of male and female CD-1 mice. (1995) (5)
Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. (1997) (5)
Induction of transplant tolerance by intrathymic inoculation of synthetic MHC class I allopeptides. (1997) (5)
Th2-type cytokines in the "infectious" tolerance pathway. (1997) (5)
Intrathymic injection of allogeneic cells induces indefinite survival of cardiac but not small bowel grafts. (1994) (5)
Looking into the crystal ball: kidney transplantation in 2025 (2009) (5)
Dawning of a New ASN Journal: Satisfying an Unmet Need in Clinical Research and Education (2005) (5)
CD 28-independent induction of experimental autoimmune encephalomyelitis (2001) (5)
Corrigendum to 'Mechanisms of PDL1-mediated regulation of autoimmune diabetes' [Clin. Immunol. 125 (2007) 16-25] (2014) (5)
Calcineurin inhibitor (CNI) avoidance in pediatric renal transplantation (RTx). (2005) (5)
Requirements for the induction of allospecific CD8+ suppressor T cells in the rat primary mixed lymphocyte response. CD4+, CD45R+ T cells, or supernatant factor. (1989) (4)
This information is current as Activation In Vitro Inhibits Human Alloimmune T Cell Specific MDR 1 P-Glycoprotein Blockade Briscoe (2001) (4)
Imaging cell biology in transplantation (2016) (4)
Regulating rejection with cell therapy (2008) (4)
The role of the B 7 costimulatory pathway in experimental cold ischemia / reperfusion injury (2013) (4)
Faculty Opinions recommendation of PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. (2009) (4)
Responses In Vivo Costimulatory Pathway in Alloimmune The Role of the CD 134-CD 134 Ligand Yagita and (2003) (4)
The arduous road to achieving an immunosuppression-free state in kidney transplant recipients (2007) (4)
Differential role of programmed death-1 ligand and programmed death-2 ligand in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis (2006) (4)
Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection. (1997) (4)
Identification of human melanoma initiating cells (2008) (4)
CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients. (1998) (4)
CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients. (1997) (4)
Challenges for the translation of T cell costimulatory blockade therapies to the clinic (2002) (4)
CTLA4Ig and donor-specific transfusion prolongs cardiac allograft survival in the miniature swine. (2001) (3)
Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin? (2006) (3)
Global vaccination strategy to eradicate COVID-19: Beyond science (2021) (3)
TNF:TNF-R T-Cell costimulatory pathways in transplantation. (2001) (3)
Intrathymic injection of donor splenocytes plus systemic antilymphocyte serum or antilymphocyte serum alone prolongs cardiac allograft survival and inhibits graft arteriosclerosis in the Lewis-to-F344 chronic rejection model. (1995) (3)
Switching immunosuppressive drugs in kidney transplant recipients: "show me the evidence". (2006) (3)
Mixed lymphocyte response-generated suppressor cell specificity in humans is major histocompatibility complex-restricted. (1989) (3)
Live Without Calcineurin Inhibitors : 40 Years Later , Can ' t (2013) (3)
(208) - Rituximab Induction and Risk of Cardiac Allograft Vasculopathy, Rejection and Death (2017) (3)
T-cell co-stimulatory blockade in kidney transplantation: back to the bench (2011) (3)
Developments in the clinical science of transplantation during the 20th century. (1998) (3)
T cell costimulatory blockade as a novel immune intervention in autoimmune diseases. (2001) (3)
Intrathymic immunomodulation of sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways. (2000) (3)
Peptide mediated immunosuppression: new developments. (1998) (3)
Kidney transplantation principles and practice, 5th edition (2002) (3)
Importance of the CD28/B7 costimulatory pathway in the development of chronic ductopenic rejection in a new model of orthotopic rat liver allotransplantation. (1997) (3)
Abrogation of accelerated allograft rejection by intrathymic injection of donor spleen cells is associated with upregulation of donor-reactive IgM, IgG1, and IgG2A, but depression of IgG2B in the circulation and at the graft site. (1995) (2)
Role of novel T-cell costimulatory pathways in transplantation (2003) (2)
Immunogenicity and Effectiveness of Primary and Booster Vaccine Combination Strategies during Periods of SARS-CoV-2 Delta and Omicron Variants (2022) (2)
The Programmed Death-1 (pd-1) Pathway Regulates Peripheral T Cell Tolerance During Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice (2007) (2)
CTLA 4 Ig-Induced Linked Regulation of Allogeneic T Cell Responses 1 (2001) (2)
In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4. (1992) (2)
Divergent Function of Programmed Death-Ligand 1 in Donor Tissue versus Recipient Immune System in a Murine Model of Bronchiolitis Obliterans. (2017) (2)
Mesenteric and intraepithelial lymphocytes are insufficient to cause rejection but able to mediate lethal graft-versus-host disease in small bowel transplants. (1994) (2)
Complement dances with T cells. (2008) (2)
New Immunosuppressive modalities and anti-rejection approaches in organ transplantation (1994) (2)
Prolongation of survival and preservation of allograft structure and function by a signaling CD28 mAB in a rat model of chronic kidney rejection. (2001) (2)
Faculty Opinions recommendation of Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. (2010) (2)
CD70-CD27 is a critical CD28-independent costimulatory pathway for alloimmune CD8+T cell responses (2003) (2)
BCL-Xl AUGMENTS T CELL SURVIVAL IN THE ABSENCE OF COSTIMULATION AND BLOCKS IMMUNOSUPPRESSION WITH CTLA4IG. (1998) (2)
Achieving clinical transplant tolerance: what are the hurdles? (2001) (2)
Dialysis and transplantation (2013) (1)
Regulation of Alloimmune Responses In Vivo Role of the Programmed Death-1 Pathway in Turka and (2005) (1)
Changes in Plasma Levels of VEGF-C and Endothelin-1 During the First Post-Transplant Year Are Predictive of Cardiac Allograft Vasculopathy: Results From the CTOT-05 Study.: Abstract# A23 (2014) (1)
Preclinical design of less immunogenic biologics: Tregitopes and Tolerance (144.28) (2010) (1)
Chapter 88 – Diagnosis and Management of Renal Allograft Dysfunction (2008) (1)
Indirect allorecognition of MHC class II peptides accellerates cardiac allograft rejection in miniature swine (2003) (1)
Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2. (1999) (1)
SENSITIZATION AGAINST DONOR MISMATCHED HLA CLASS II PEPTIDES IN LUNG TRANSPLANT RECIPIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME (1999) (1)
Faculty Opinions recommendation of Regulation of conformer-specific activation of the integrin LFA-1 by a chemokine-triggered Rho signaling module. (2009) (1)
Anti-CD3 mAb treatment cures PDL1-/-.NOD mice of diabetes but precipitates fatal myocarditis. (2011) (1)
FLOW CYTOMETRIC ANALYSIS OF INTRACELLULAR CYTOKINE PRODUCTION IN RENAL TRANSPLANT RECIPIENTS (1999) (1)
Introduction: Nephrology Hall of Fame for CJASN (2009) (1)
Overview: future approaches to renal replacement and regeneration. (2004) (1)
TIM-1 Plays a Crucial Role in the Expansion of Autopathogneic T-Cells and Regulation of Autoimmunity (2006) (1)
LONG-TERM SURVIVAL OF CARDIAC ALLOGRAFTS INDUCED BY COSTIMULATORY BLOCKADE MAY REQUIRE INDIRECT RECOGNITION (1999) (1)
The role of T-cell costimulatory pathways in ischemia—reperfusion injury (1998) (1)
Tolerance is the achievable ‘Holy Grail’ in transplantation (2006) (1)
INDUCTION OF MIXED HEMATOPOIETIC CHIMERISM AND TOLERANCE WITH SUBOPTIMAL RECIPIENT T CELL DEPLETION, 3GY TBI AND ANTI-CD154 OR CTLA4Ig: TOWARD A CLINICAL REGIMEN USEFUL FOR CADAVERIC DONORS (1999) (1)
CD40 ligand-CD40 T cell costimulation pathway is required for host sensitization in the immune cascade leading to accelerated allograft rejection. (2001) (1)
Chronic renal allograft dysfunction (CAD): new frontiers. Introduction. (2010) (1)
This information is current as Memory T Cell-Mediated Rejection Critical , but Conditional , Role of OX 40 in LiLaurence (2006) (1)
Chronic Rejection Rejection: Implications for Therapy of Allograft of FTY720 in a Transgenic Model of Novel Insights into the Mechanism of Action (2005) (1)
Heart Allografts Are under Strict Regulation Rejection of Single Class II MHC-Disparate Alloreactive T Cell Responses and Acute and (2005) (1)
Harnessing negative T‐cell costimulatory pathways to promote engraftment (2007) (1)
Characterization of donor dendritic cells and enhancement of dc efflux with cc-chemokine ligand 21 : a novel strategy to prolong islet allograft survival (2007) (1)
Sizzling Issues in Clinical Renal Transplantation (2010) (1)
SUBSTANTIAL DONOR CHIMERISM AND TOLERANCE ACROSS A FULL MHC BARRIER WITHOUT HOST PRE-CONDITIONING (1999) (1)
TNP-470, AN ANGIOGENESIS INHIBITOR, INTERRUPTS THE DEVELOPMENT OF GRAFT ARTERIOSCLEROSIS IN A RAT CARDIAC MODEL OF CHRONIC ALLOGRAFT REJECTION (1999) (1)
CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients. (1997) (1)
THE DIFFERENTIAL ROLE OF CD28‐B7 VERSUS CD40L‐CD40 IN REGULATING ALLOIMMUNE RESPONSES IN STAT 4 VERSUS STAT 6 GENE KNOCKOUT MICE.: Abstract# 1027 (2000) (1)
DIFFERENTIAL MECHANISMS OF THE IMMUNOMODULATORY FUNCTIONS OF PEPTIDES DERIVED FROM CONSERVED REGIONS OF CLASS II MHC. (1999) (1)
Response to letter to the editor: Immunophenotyping of SARS-CoV-2 and vaccine design (2022) (1)
HLA-DR restricted binding of sleep inducing muramyl peptides to B cells of normals and narcoleptic subjects (1988) (1)
Elevated levels of soluble HLA class I in the serum of multiple sclerosis patients (1994) (0)
RAT CD28 SPECIFIC MONOCLONAL ANTIBODY: ITS POTENTIAL ROLE IN ACTIVATION INDUCED CELL DEATH AND PREVENTION OF ACUTE VASCULARIZED CARDIAC ALLOGRAFT REJECTION (1999) (0)
INTERFERENCE WITH T CELL ACTIVATION SIGNAL ONE AND SIGNAL TWO WITH A COMBINATION OF ANTI-CD45RB AND ANTI-CD40L MONOCLONAL ANTIBODIES INDUCES LONG-TERM ISLET ALLOGRAFT SURVIVAL IN MICE (1998) (0)
Activated protein C binds to A 50-55 KD receptor on human monocytes and inhibits cytokine production, mitogen responses and calcium signalling (1994) (0)
GENETIC BASIS OF RESISTANCE TO TRANSPLANTATION TOLERANCE INDUCTION IN NOD MICE. (2006) (0)
430: Apoptosis Is an Effector Mechanism of Acute Cardiac Allograft Rejection: Involvement of Proteolytic Bcl-2 Degradation (2008) (0)
Faculty Opinions recommendation of Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. (2009) (0)
in Alloimmune Responses CD28-independent Costimulation of T Cells (2001) (0)
IL-17-Dependent Mechanism Intra-abdominal Sepsis by an T Cells Mediate Abscess Formation in + CD 4 (2003) (0)
POST‐TRANSPLANT DE NOVO AUTOIMMUNITY CONTRIBUTES TO CARDIAC ALLOGRAFT REJECTION AND IT IS MEDIATED VIA INDIRECT PRESENTATION OF DONOR MHC PEPTIDES AND ORGAN‐SPECIFIC AUTOANTIGENS.: Abstract# 5 (2000) (0)
CD40L COSTIMULATORY PATHWAY IS REQUIRED FOR HOST SENSITIZATION AND ITS BLOCKADE ABROGATES ACCELERATED GRAFT REJECTION IN PRESENSITIZED HOSTS.: Abstract# 2 (2000) (0)
TNP-470, AN ANTI-ANGIOGENESIS AGENT, IS A POTENT INHIBITOR OF HUMAN CD4+ T CELL PROLIFERATION (1999) (0)
O808 - Inhibition of the alloimmune response by synthetic peptides derived from highly conserved regions of class II MHC alpha chain (1996) (0)
CHARACTERIZATION OF MHC ALLOPEPTIDE REACTIVE T CELL CLONES FROM HUMAN RENAL ALLOGRAFT RECIPIENTS (1998) (0)
Faculty Opinions recommendation of Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. (2011) (0)
HUMAN ALLOGRAFT REJECTION IS MEDIATED BY CD4+ T CELLS IN SCID MICE TRANSPLANTED WITH HUMAN THYMUS AND LIVER (THY/LIV SCID MICE).: Abstract# 719 (2000) (0)
HIGH LEVELS OF STABLE MULTI-LINEAGE HEMATOPOIETIC CHIMERISM AND DONOR-SPECIFIC ALLOGENEIC SKIN GRAFT TOLERANCE WITH T-CELL COSTIMULATORY BLOCKADE (1998) (0)
Faculty Opinions recommendation of The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo. (2009) (0)
SYNERGY BETWEEN SIGNAL 1 PLUS SIGNAL 2 BLOCKADE IN A STRINGENT MODEL OF ALLOGRAFT REJECTION.: Abstract# 998 (2000) (0)
Renal Transplantation: Introduction (2007) (0)
The role of B7 and CD2 family costimulatory molecules in natural killer cell function (2003) (0)
OR.89. Notch Signaling Regulates Experimental Autoimmune Encephalomyelitis: Crosstalk Between Autoreactive T‐Cells and Astrocytes (2006) (0)
Changes in Plasma Levels of VEGF-C and Endothelin-1 During the First Post-Transplant Year Are Predictive of Cardiac Allograft (2017) (0)
INDIRECT ALLORECOGNITION OF DONOR CLASS II MHC PEPTIDES INDUCES ANTIBODY MEDIATED VASCULAR REJECTION OF CARDIAC ALLOGRAFTS (1998) (0)
Oxide in Response to Self- and Alloantigens Nitric Oxide Synthase and Generate Nitric Thymic Dendritic Cells Express Inducible (2000) (0)
The Role of CX3CR1 in dDC (Donor Dendritic Cells) Trafficking in Cardiac Transplant Model.: Abstract# B760 (2014) (0)
BLOCKADE OF SIGNALS ONE AND TWO UTILIZING ANTI-CD45RB AND ANTI-CD40L SYNERGIZES TOLERANCE INDUCTION IN ISLET ALLOTRANSPLANTATION (1999) (0)
HUMAN ENDOTHELIAL CELLS PROMOTE THE DIFFERENTIATION OF MONOCYTES INTO DENDRITIC CELLS AND FACILITATE INDIRECT ALLORECOGNITION (1999) (0)
GENERATION AND CHARACTERIZATION OF CLASS II MHC ALLOPEPTIDE SPECIFIC Th1/Th2 CLONES FROM REJECTING AND TOLERANT ANIMALS IN AN EXPERIMNETAL RAT KIDNEY TRANSPLANT MODEL (1999) (0)
SPECIFICITY AND FUNCTION OF CD4+ CD25+ REGULATORY T CELLS IN A NOVEL CD4+ TCR-TRANSGENIC MODEL OF ALLOIMMUNITY (2004) (0)
Faculty Opinions recommendation of Intracellular MHC class II controls regulatory tolerance to allogeneic transplants. (2011) (0)
Alloreactive T Cell Clone Size + Alloimmunity : Cytokines , CTLA-4 , CD 25 Physiological Mechanisms of Regulating (2002) (0)
Effect of targeting BTLA-HVEM co-inhibitory pathway in partial MHC-mismatched cardiac grafts (2006) (0)
Allografts After Costimulatory Blockade Long-Term Survival of Murine Cardiac Expression Is Required to Achieve Cutting Edge: Recipient MHC Class II (2001) (0)
Antibodies to a homologue of MDR-P-glycoprotein on chromosome 7p15-21 and Uses Thereof (2001) (0)
Acquired tolerance to EAE by intrathymic injection of MBP peptides: Role of thymic dendritic cells (1994) (0)
The role of CD25+regulatory cells in restoring tolerance in autoimmune anti-GBM (Goodpasture's) disease. (2002) (0)
TARGETING CHEMOKINE RECEPTORS CXCR3 AND CCR5 REDUCES RENAL ISCHEMIC INJURIES (2004) (0)
Expansion and characterization of CD4(+)CD25(+) regulatory T-cells from human renal transplant recipients. (2003) (0)
AN INTACT PD1/PDL1 PATHWAY IS REQUIRED FOR INDUCTION OF TRANSPLANTATION TOLERANCE BY CD28-B7 OR CD154-CD40 COSTIMULATORY BLOCKADE. (2006) (0)
ABCB 5 Identifies Immunoregulatory Dermal Cells Graphical Abstract Highlights (2018) (0)
IN VIVO MECHANISMS OF TRANSPLANTATION TOLERANCE BY SIGNAL ONE BLOCKADE WITH &agr;‐CD45RB: ROLE OF CTLA4 NEGATIVE T CELL COSTIMULATORY PATHWAY.: Abstract# 356 (2000) (0)
Methods for immunomodulation (2004) (0)
ORGANIZATION, STRUCTURE AND SEQUENCE OF THE RAT TCR BETA GENOMIC LOCI (1999) (0)
Comprar Chronic Kidney Disease, Dialysis, and Transplantation, 3rd Edition | Mohamed Sayegh | 9781437709872 | Saunders (2010) (0)
Chapter 31 – Transplantation Immunobiology (2005) (0)
Induced costimulatory molecule-B7h costimulatory pathway in alloimmune regulation (2005) (0)
LATE BLOCKADE OF B7-1 COSTIMULATION INTERRUPTS THE DEVELOPMENT OF CHRONIC REJECTION IN A RAT MODEL OF CARDIAC TRANSPLANTATION. (1998) (0)
Faculty Opinions recommendation of T cell allorecognition via molecular mimicry. (2010) (0)
CD28: beyond just T-cell costimulation (2007) (0)
Faculty Opinions recommendation of TLR signals promote IL-6/IL-17-dependent transplant rejection. (2009) (0)
The T Cell Response to Transplantation Antigens (2012) (0)
Comprar Core Concepts in Renal Transplantation | Chandraker, Anil | 9781461400073 | Springer (2011) (0)
RETENTION OF REGULATORY ACTIVITY IN CD4+CD25+ T-CELLS ISOLATED FROM RENAL TRANSPLANT RECIPIENTS FOLLOWING EX-VIVO EXPANSION (2004) (0)
Faculty Opinions recommendation of Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation. (2009) (0)
EXPLORATION OF THE ROLE OF B7H4 IN CHRONIC ALLOGRAFT VASCULOPATHY: 1529 (2008) (0)
Alloreactive T Cell Clone Size Cells, and the + CTLA-4, CD25 Regulating Alloimmunity: Cytokines, Physiological Mechanisms of (2010) (0)
The role of the novel gene, T-bet, in allograft rejection and tolerance. (2003) (0)
Immunogenicity of class II MHC allopeptides in vivo (1992) (0)
Survival of Allogeneic Heart Transplants Response to Cardiac Myosin Can Prolong Modulation of Tissue-Specific Immune (2002) (0)
VivoChemokine/Chemokine Receptor Function In Allograft Rejection: Tissue Specificity of Differential Role of CCR2 in Islet and Heart (2003) (0)
Overcome It T Cell Depletion and Approaches to Accelerated Memory Cell Homeostasis during (2006) (0)
DETERMINATION OF THE ALLOREACTIVE T CELL FREQUENCY IN VIVO: WHAT YOU GET DEPENDS UPON WHAT YOU MEASURE.: Abstract# 151 (2000) (0)
BLOCKING OX40 COSTIMULATION OR MTOR IS REQUIRED TO PREVENT CD8+ MEDIATED REJECTION (2004) (0)
Regulation of autoimmune diabetes in NOD mice: Critical role for the PD-1 : PD-L1 costimulatory pathway. (2002) (0)
Th1-specific transcription factor T-bet-deficiency - a new model of acute and accelerated chronic vascular allograft rejection (2005) (0)
Presidential & Awards Session (2011) (0)
ROLE OF CD4 AND CD8 T CELLS IN VASCULARIZED CARDIAC ALLOGRAFT REJECTION MEDIATED BY DIRECT AND INDIRECT ALLORECOGNITION.: Abstract# 498 Poster Board #‐Session: P138‐II (2000) (0)
CONCURRENT SESSION 4: GENERATION AND FUNCTION OF TREGS (2006) (0)
INDUCTION OF TOLEROGENIC DENDRITIC CELLS BY TARGETING CHEMOKINE RECEPTOR CCR2 IN ISLET CELL TRANSPLANTATION. (2006) (0)
Cells in Fetomaternal Tolerance A Link between PDL1 and T Regulatory (0)
Experimental Autoimmune Type 1 Diabetes Marrow-Derived Mesenchymal Stem Cells in Immunomodulatory Function of Bone (2009) (0)
Agonistic and antagonistic interactions between CTLA4Ig and donor alloantigens in sensitized rat recipients of cardiac allografts. (1998) (0)
MHC ALLOPEPTIDE REACTIVE T CELL CLONES GENERATED FROM HUMAN RENAL ALLOGRAFT RECIPIENTS: INDIRECT ALLORECOGNITION IN LONG TERM ENGRAFTMENT (1999) (0)
Following Islet Transplantation by Gene Prevention of Recurrent Type 1 Diabetes Induction of Robust Diabetes Resistance and Donnarumma (2007) (0)
793. Induction of Molecular Chimerism in NOD Mice Is Resistant to the Occurrence of Type I Diabetes Induced by Blockade of the Programmed Death-1 Pathway (2006) (0)
COSTIMULATION IN TRANS CAN MEDIATE ACUTE REJECTION OF CARDIAC ALLOGRAFTS.: Abstract# 1164 (2000) (0)
Programmed Death-1 Inhibitory Pathway Regulation of Postsurgical Fibrosis by the and (2004) (0)
CTLA4Ig INDUCES REGULATORY T CELLS THAT MEDIATE LINKED REGULATION OF ALLOGENEIC T CELL RESPONSES.: Abstract# 1101 (2000) (0)
Xenogeneic Human Anti-Porcine T Cell Prevents Costimulation of Allogeneic Porcine Blockade of CD 28B 7 , But Not CD 40-CD 154 , (2000) (0)
THE ROLE OF CTLA4-MEDIATED NEGATIVE SIGNALS AND CELL SURVIVAL IN TOLERANCE INDUCTION BY BLOCKADE OF B7:CD28 AND CD40:CD40L (CD154). (1999) (0)
Faculty Opinions recommendation of TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. (2008) (0)
Diabetes mellitus - basic research (2009) (0)
Novel Strategies Using MHC Peptides (2001) (0)
CD4+ CD25+ regulatory T cells mediate antigen-specificity in a novel TCR transgenic model of alloimmunity (2005) (0)
In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity (2012) (0)
AnergyApoptosis of Thymocytes and Peripheral T Cell Vivo: Intrathymic Injection of Antigen Induces Mechanisms of Acquired Thymic Tolerance In (1998) (0)
Invitation for Commentary (2006) (0)
EARLY DELETION AFTER BONE MARROW TRANSPLANTATION WITH COSTIMULATORY BLOCKADE IS FAS-DEPENDENT AND IS PREVENTED BY BCL-XL OVEREXPRESSION (1999) (0)
INDUCTION OF APOPTOSIS BY A MHC CLASS II DERIVED PEPTIDE THROUGH A CASPASE INDEPENDENT PATHWAY.: Abstract# 880 Poster Board #‐Session: P137‐III (2000) (0)
Inhibiting Alloimmune Responses In Vivo Ligand 1/B7.1 Pathway Is Functional in The Novel Costimulatory Programmed Death (2011) (0)
Acute Cardiac Allograft Rejection: Involvement of Apoptotic Cell Death and Proteolytic Bcl-2 Degradation (1999) (0)
Faculty Opinions recommendation of Development and characterization of IL-21-producing CD4+ T cells. (2008) (0)
MODULATORS OF P-GLYCOPROTEIN-MEDIATED TRANSMEMBRANE TRANSPORT INHIBIT T-CELL PROLIFERATION IN VITRO (1999) (0)
P‐GLYCOPROTEIN FUNCTION IN HUMAN ALLOIMMUNE INTERACTIONS.: Abstract# 78 (2000) (0)
Abstract 540: Correlation of Improved Cholesterol Efflux Capacity of High Density Lipoprotein With Survival and Allograft Vasculopathy in Cardiac Transplant Recipients (2015) (0)
Allograft Acceptance by TLR Ligands Mechanisms Underlying Blockade of (2008) (0)
DO HUMAN ENDOTHELIAL CELLS UTILIZE THE CD28/B7 PATHWAY TO COSTIMULATE CD4+ T CELL ACTIVATION? (1998) (0)
Prolongation of heart allograft survival by modulating of tissue-specific response requires low frequency of alloreactive T cells (2002) (0)
AST Officers, Committees (2003) (0)
Introduction: Conflict Nephrology Revisited. (2020) (0)
For a homologous the human, responsible for multiple resistance, p-glycoprotein on chromosome 7p15-21 coding gen and uses therefor (2001) (0)
T CELL COSTIMULATORY BLOCKADE SUPPRESSES INDIRECT BETTER THAN DIRECT ALLOIMMUNE RESPONSES IN VIVO (1998) (0)
Moving points in pediatric nephrology and transplantation (1997) (0)
Introducing Presse Rénale (2007) (0)
INDUCTION OF TOLERANCE BY SIGNAL ONE BLOCKADE WITH ANTI-CD45RB REQUIRES NEGATIVE SIGNALING THROUGH CTLA-4. (1999) (0)
Renal Transplantation Incidence of cancers in people with HIV/ AIDS compared with immunosuppressed transplant recipients: A meta-analysis. (2007) (0)
Su.26. PDL1 Regulates Autoimmunity By Limiting Expansion of Autoreactive Th1 Cells and Mediates Resistance to Diabetes in Nod Mice (2006) (0)
Diff erential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and eff ector function (2007) (0)
Abstract 512: Fibroblasts Associated with Cardiac Fibrosis Carry Endothelial Imprint: Implication for Endothelial to Mesenchymal Transition (2006) (0)
CellsProtection of Human Mesenchymal Stem The Novel Role of SERPINB9 in Cytotoxic (2011) (0)
Erratum: Promotion of altruistic donation (Transplantation (2009) (847)) (2009) (0)
New therapies Maintenance pharmacological immunosuppressive strategies in renal transplantation (2003) (0)
EXPLORATION OF THE ROLE OF THE NOVEL B7 FAMILY MEMBER B7H4 IN CHRONIC REJECTION: 1531 (2008) (0)
TRANSPLANT SPECIFIC TOLERANCE AFTER TRANSFER OF ALLOPEPTIDE SPECIFIC TH2-, BUT NOT OF TH1 CELL CLONES, IS ASSOCIATED WITH GATA-3 EXPRESSION IN THE GRAFT AND REGULATION OF THE IMMUNE RESPONSE (2004) (0)
CD28:B7 BLOCKADE PREVENTS TRANSPLANT VASCULOPÁTHY AND MONONUCLEAR CELL INFILTRATION IN A FULLY ALLOGENEIC CARDIAC TRANSPLANT MODEL (1998) (0)
Minimisation of immunosuppression in transplantation – Authors' reply (2007) (0)
NON‐IMMUNOLOGIC MECHANISMS OF ISLET ALLOGRAFT DYSFUNCTION: EFFECT OF DIABETES CONTROL ON ISLET ALLOGRAFT DYSFUNCTION.: Abstract# 370 Poster Board #‐Session: P10‐II (2000) (0)
IMMUNOMODULATORY FUNCTION OF LOW MOLECULAR WEIGHT HYALURONATE DELAYS ALLOGRAFT REJECTION AND IMPROVES SURVIVAL IN A RAT ACUTE KIDNEY REJECTION MODEL. (1998) (0)
CORRECTION (2003) (0)
THE ROLE OF CTLA4 NEGATIVE SIGNALING PATHWAY IN THE INDUCTION OF ACQUIRED THYMIC TOLERANCE IN VIVO (1998) (0)
Multicenter Study to Determine Up to 5 Year Clinical Outcome of Heart Transplant Recipient Receiving Rituximab Versus Placebo Outcomes in Subjects Previously Randomized in the CTOT-11 Study (2018) (0)
Immunobiology of Allograft Destruction (1996) (0)
Autoimmune Disease Model Tolerance in a Clinically Relevant in the Initiation and Maintenance of Acquired Thymic Tolerance : Role of CTLA 4 and (1998) (0)
INDUCTION OF DONOR SPECIFIC ACQUIRED THYMIC TOLERANCE BY INTRATHYMIC INOCULATION OF A SINGLE SYNTHETIC ALLO-MHC CLASS I PEPTIDE [RT1.Au] (1998) (0)
MECHANISMS OF ISLET ALLOGRAFT REJECTION: ROLE OF AUTOIMMUNITY AND EFFECT OF T CELL COSTIMULATORY BLOCKADE.: Abstract# 898 Poster Board #‐Session: P155‐III (2000) (0)
through Enhanced CTLA-4 Expression Cutting Edge: Transplantation Tolerance (2003) (0)
PRE-TRANSPLANT DONOR-SPECIFC TRANSFUSIONS COMBINED WITH CYCLOSPORINE BUT NOT WITH RAPAMYCIN INDUCE TOLERANCE TO MHC CLASS I-MISMATCHED CARDIAC ALLOGRAFTS IN MINIATURE SWINE (2004) (0)
Faculty Opinions recommendation of Allo-HLA reactivity of virus-specific memory T cells is common. (2010) (0)
Tolerance: Is it time to Move to the Clinic? (2001) (0)
CHALLENGING CURRENT DOGMAS: DONOR BONE MARROW T CELLS ARE REQUIRED FOR INDUCTION OF DURABLE TOLERANCE TO SKIN ALLOGRAFTS BY MIXED ALLOGENEIC CHIMERISM. (2006) (0)
542 Incidence of Coronary Artery Vasculopathy Has Decreased with Modern Immunosuppression: Insights from Clinical Trials in Organ Transplantation (2011) (0)
Suppressor cells generated between family members exhibit major histocompatibility complex restriction (1988) (0)
A gene encoding a homologue of human P-glycoprotein multidrug-resistant in chromosome 7p15-21 and uses thereof (2001) (0)
TolerancePathway and Th17 in Fetomaternal The Link between the PDL1 Costimulatory (2011) (0)
Therapeutic strategies targeted at CD4+ cells obviate accelerated rejection of cardiac allografts in sensitized rats. (1991) (0)
RENAL TRANSPLANTATION (1996) (0)
I m m u n o s u p p ressive strategies in transplantation (1999) (0)
A SIGNALING CD28 ANTIBODY PROLONGS SURVIVAL AND PRESERVES RENAL ALLOGRAFT STRUCTURE AND FUNCTION IN A RAT MODEL OF CHRONIC REJECTION.: Abstract# 1169 (2000) (0)
Rivers to Cross Clinical Transplantation Tolerance : Many (2007) (0)
Faculty Opinions recommendation of Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. (2009) (0)
Faculty Opinions recommendation of The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats. (2008) (0)
Chapter 32 – Transplantation Immunobiology (2010) (0)
Mechanisms of Acquired Thymic Tolerance in Experimental Autoimmtme Encephalomyelitis: Thymic Dendritic-enriched Cells Induce Specific Peripheral T Cell Unresponsiveness In Vivo By Samia J. Khoury,* Lorenzo Gallon, Wanjun Chen,* (1995) (0)
B7‐1 IS THE DOMINANT LIGAND FOR CTLA‐4 DOWN REGULATION OF ALLOIMMUNE RESPONSES IN VIVO.: Abstract# 1157 (2000) (0)
Functions of the PD-1: PD-L1 costimulatory pathway in physiologic regulation of alloimmune responses in vivo (2003) (0)
OR.107. TIM-1 Plays a Crucial Role in the Expansion of Autopathogneic T-Cells and Regulation of Autoimmunity [abstract only] (2006) (0)
DISTINCT TOLERANCE PATHWAYS IN SENSITIZED GRAFT RECIPIENTS (1998) (0)
Cell-Mediated Rejection T + and CD 8 + Requirements for CD 4 Different Costimulatory and Growth Factor (2004) (0)
Post-transplantation hypertension. (2000) (0)
ROLES OF DONOR-DERIVED SELECTINS IN THE DEVELOPMENT OF BOTH ACUTE REJECTION AND GRAFT ARTERIOSCLEROSIS. (2006) (0)
PASSIVE T CELL DEATH IS NOT REQUIRED FOR INDUCTION OF TRANSPLANTATION TOLERANCE TO MINOR HISTOCOMPATIBILITY ANTIGENS MISMATCHED ALLOGRAFTS.: Abstract# 134 (2000) (0)
Differential Gene Expression Identifies Novel Markers of Myelin-Specific Murine Memory CD4+ T Cells (2007) (0)
Cell Death Activation-Induced Cell Death and Passive Blockade Has Features of Both Transplantation with Costimulatory Peripheral Deletion After Bone Marrow (2001) (0)
Regulatory phenotype is enriched in the CD25 'high' sub-population of CD4(+)CD25(+) cells expanded from renal transplant recipients. (2004) (0)
PREVENTION OF GRAFT ARTERIOSCLEROSIS MEDIATED BY INDIRECT ALLORECOGNITION USING A SIGNALING CD28 ANTIBODY.: Abstract# 1168 (2000) (0)
This information is current as via Programmed Death Ligand 1 Cells and Prolongs Islet Allograft Survival Mobilizes Autologous Hematopoietic Stem CXCL12 Axis - Targeting the CXCR4 (2012) (0)
Faculty Opinions recommendation of Contribution of naïve and memory T-cell populations to the human alloimmune response. (2009) (0)
Understanding how Tregs are regulated: therapeutic implications. (2009) (0)
ALLOGENEIC ENDOTHELIUM INDUCES B7-2 EXPRESSION IN TRANSMIGRATING LEUKOCYTES. (1998) (0)
Generation of regulatory CD8(+) T cells by ICOS-B7h signal blockade in vivo. (2004) (0)
REPLY: DISCREPANCY IN PEPTIDES SERIOUSLY DAMAGES STUDY (1997) (0)
POST‐TRANSPLANT AUTOIMMUNITY TO CARDIAC MYOSIN CAN BE DETECTED DURING INITIAL STAGES OF CHRONIC REJECTION OF CARDIAC ALLOGRAFTS.: Abstract# 4 (2000) (0)
Faculty Opinions recommendation of Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes. (2010) (0)
THE TH1/TH2 PARADIGM REVISITED: REGULATORY FUNCTIONS OF ALLOREACTIVE TH2 CLONES IN VIVO.: Abstract# 144 (2000) (0)
EFFECTS OF SELECTIVE CD28:B7-1 BLOCKADE IN ACUTE CARDIAC ALLOGRAFT REJECTION (1998) (0)
NEW INSIGHTS INTO ICOS-B7h PATHWAY IN ALLOIMMUNE RESPONSE (2004) (0)
Tolerance induction for islet transplantation in stringent models. (2003) (0)
Coichicine Interferes with L-Selectin and Leukocyte Function-Associated Antigen-i Expression on Human I Lymphocytes a nd Inhibits I Cell (1996) (0)
INDIRECT RECOGNITION OF DONOR CLASS I PEPTIDES INDUCES AND ACCELERATES CARDIAC ALLOGRAFT VASCULOPATHY IN THE MINIATURE SWINE.: Abstract# 1004 (2000) (0)
DICHOTOMY OF PD-L1 AND PD-L2 PATHWAYS IN NEGATIVELY REGULATING ALLOREACTIVE CD4+ AND CD8+ T CELLS (2004) (0)
Blockade of T-cell costimulatory pathways protects from experimental autoimmune encephalomyelitis in Th2 deficient mice (2002) (0)
Responses and Xenogeneic Human Anti-Porcine T Cell Prevents Costimulation of Allogeneic Porcine Blockade of CD28-B7, But Not CD40-CD154, (2000) (0)
a Reciprocal Cytokine Environment In Vivo Defining Th1 and Th2 Immune Responses in (2013) (0)
Medical management of kidney transplantation (2005) (0)
Correction (1976) (0)
326: Novel Role of the Tim-4 Molecule in Alloimmunity (2010) (0)
Novel and conventional costimulatory blockades for tolerance induction in cardiac allotransplanation (2003) (0)
Visualization of alloreactive CD4 T cell responses and tolerance induction in vivo (2003) (0)
936-85 Intrathymic Injection of Donor Splenocytes Prolongs Rat Cardiac Allograft Survival but Does not Inhibit Graft Arteriosclerosis (1995) (0)
CJASN: Passing the Torch (2010) (0)
Function in Alloimmunity Regulatory T Cell + CD25+ Specificity of CD4 (0)
CJASN Matures to a Monthly Journal (2009) (0)
Renal Transplantation: What's New? (2008) (0)
Blockade In Vivo Regulatory T Cell Induced by ICOS-B 7 h + PD 1 + A Novel Alloantigen-Specific CD 8 Sayegh and (2007) (0)
Chronic rejection from bedside to bench: role of T cells. (1997) (0)
29: Expansion of CD4+CD25+FoxP3+ Regulatory T Lymphocytes with Low-Dose Anti-Thymocyte Globulin Leads to Prolonged Survival of Cardiac Allografts but Not Tolerance (2009) (0)
Erratum: (The Journal of Experimemal Medicine (July 7, 2003) 198:1 (71-78)) (2003) (0)
T Cells by Skin Grafts Via Direct + CD 8 ofPathway Is Required for Host Sensitization The CD 154-CD 40 T Cell Costimulation (2002) (0)
CD8+ T Cells by Skin Grafts Via Direct of Pathway Is Required for Host Sensitization The CD154-CD40 T Cell Costimulation (2013) (0)
Human Tolerance Maternal Acceptance of the Fetus: True (2013) (0)
Activation In Vitro Inhibits Human Alloimmune T Cell Specific MDR1 P-Glycoprotein Blockade (2013) (0)
CD 154-Independent Rejection Critical Role of OX 40 in CD 28 and Sayegh and (2004) (0)
Tolerance in Stringent Transplant Models Promotes Long Term Engraftment and Synergizes with CD40 Ligand Blockade and Targeting Signal 1 Through CD45RB (2000) (0)
T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection1 (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mohamed Hassan Sayegh?

Mohamed Hassan Sayegh is affiliated with the following schools:

Mohamed Hassan Sayegh's Academic­Influence.com Rankings

Why Is Mohamed Hassan Sayegh Influential?

Mohamed Hassan Sayegh's Published Works

Published Works

What Schools Are Affiliated With Mohamed Hassan Sayegh?

Mohamed Hassan Sayegh's AcademicInfluence.com Rankings